IMPL

Olfera

Olfera develops biopharmaceutical delivery solutions using an olfactory platform to transport drugs directly to the brain for patients with neurological conditions.

Miist Therapeutics

This company develops inhaled drug delivery devices providing rapid symptom relief for patients suffering from migraines or seeking smoking cessation.

HRMY

This pharmaceutical company develops and commercialises therapies for patients with rare neurological disorders and central nervous system diseases.

AQUILON PHARMACEUTICALS

The company develops inhaled medicines and nasal sprays for patients with asthma, chronic obstructive pulmonary disease and other respiratory conditions.

Noema Pharma

This company develops clinical-stage therapeutic products for patients with central nervous system disorders and orphan neurological conditions.

Salvia

The company develops minimally invasive, ultra-thin bioelectronic implants providing neuromodulation therapy for patients suffering from chronic migraines.

Herantis Pharma

This clinical-stage biotechnology company develops neurorestorative drug therapies for patients living with Parkinson's disease.

EnClear Therapies

The company develops a drug delivery system for the cerebrospinal fluid to treat patients with neurological diseases and brain tumours.